Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

In vitro anticancer activity of N-benzyl 1,10-phenanthroline derivatives on human cancer cell lines and their selectivity

Indonesian Journal of Biotechnology · Vol. 23 No. 2 (2018) · hlm. 68–73

DOI
10.22146/ijbiotech.33997
ISSN
2089-2241, 0853-8654
Terbit
2018-12-24
Penerbit
Universitas Gadjah Mada
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-sa/4.0

Abstrak

This research was conducted to evaluate the anticancer activity of new compounds of benzyl-1,10- phenanthroline derivatives and their selectivity. In vitro anticancer activity of 11 benzyl-1,10-phenanthroline derivatives were conducted on three human cancer cell lines, cervical cancer (HeLa), myeloma (NS-1), and breast cancer (MCF-7) using MTT-based cytotoxicity assay. The cytotoxicity of each compound was assessed to normal Vero cell line by the same method. The in vitro anticancer activity and cytotoxicity was expressed by the concentration inhibiting 50% of the cell growth (IC50), and the selectivity index (SI) was determined by calculating ratio of the IC50 on Vero cell line and the human cancer cell lines. The results showed that among the 11 compounds tested, the (1)-N-(4-butoxybenzyl)-1,10-phenanthrolinium bromide exhibited the best in vitro anticancer activity with an IC50 27.60 ± 2.76 µM on HeLa, 6.42 ± 5.53 µM on NS-1 and 9.44 ± 2.17 µM on MCF-7 cell lines. Its SI were 377.65 ± 39.97 on HeLa, 6158.72 ± 5306.34 on NS-1 and 1140.11 ± 261.85 on MCF-7 cell lines. This study demonstrated that (1)-N-(4-butoxybenzyl)-1,10-phenanthrolinium bromide possessed a potential in vitro anticancer activity on cancer cell lines with high selectivity

Kata kunci

Jaringan kolaborasi para penulis

31 penulis · 90 tautan kepenulisan bersama · 30 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Gadjah Mada
  • Universitas Muhammadiyah Semarang
  • Jenderal Soedirman University
  • Universitas Pattimura
  • IPB University
  • Indonesian Institute of Sciences
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Michael Haryadi WibowoUniversitas Gadjah Mada2
Ferdinand Prayogo Cahyo SantosoUniversitas Gadjah Mada1
Rini WidayantiUniversitas Gadjah Mada1
Widya AsmaraUniversitas Gadjah Mada1
Jaka WidadaUniversitas Gadjah Mada1
Alimuddin AlimuddinIPB University1
Reni NurjasmiAfiliasi tidak diketahui1
Tri WibawaUniversitas Gadjah Mada1
Maya Dian RakhmawatieUniversitas Muhammadiyah Semarang1
Puspita LisdiyantiIndonesian Institute of Sciences1
Kanti RatnaningrumUniversitas Muhammadiyah Semarang1
Muhammad Mucharom Chairul UmamUniversitas Muhammadiyah Semarang1
Muhammad Hasan AlfiUniversitas Muhammadiyah Semarang1
Listya ChaririUniversitas Muhammadiyah Semarang1
Sugiyono SugiyonoJenderal Soedirman University1
Tri UntariAfiliasi tidak diketahui1
Yuli Purwandari KristianingrumUniversitas Gadjah Mada1
Sugi WinarsihAfiliasi tidak diketahui1
Bambang SutrisnoUniversitas Gadjah Mada1
Joko SetyonoJenderal Soedirman University1
Saryono SaryonoJenderal Soedirman University1
Dwi Adi NugrohoJenderal Soedirman University1
Yehezkiel Steven KurniawanUniversitas Gadjah Mada1
Chairil AnwarUniversitas Gadjah Mada1
Putri Dian AnggraeniUniversitas Gadjah Mada1
Yaldiera UtamiUniversitas Gadjah Mada1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://jurnal.ugm.ac.id/ijbiotech/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 8 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">In vitro anticancer activity of N-benzyl 1,10-phenanthroline derivatives on human cancer cell lines and their selectivity</dc:title>
	<dc:creator>Sholikhah, Eti Nurwening</dc:creator>
	<dc:creator>Jumina, Jumina</dc:creator>
	<dc:creator>Widyarini, Sitarina</dc:creator>
	<dc:creator>Hadanu, Ruslin</dc:creator>
	<dc:creator>Mustofa, Mustofa</dc:creator>
	<dc:subject xml:lang="en-US">cytotoxicity; human cancer cell lines; in vitro anticancer activity; selectivity index</dc:subject>
	<dc:description xml:lang="en-US">This research was conducted to evaluate the anticancer activity of new compounds of benzyl-1,10- phenanthroline derivatives and their selectivity. In vitro anticancer activity of 11 benzyl-1,10-phenanthroline derivatives were conducted on three human cancer cell lines, cervical cancer (HeLa), myeloma (NS-1), and breast cancer (MCF-7) using MTT-based cytotoxicity assay. The cytotoxicity of each compound was assessed to normal Vero cell line by the same method. The in vitro anticancer activity and cytotoxicity was expressed by the concentration inhibiting 50% of the cell growth (IC50), and the selectivity index (SI) was determined by calculating ratio of the IC50 on Vero cell line and the human cancer cell lines. The results showed that among the 11 compounds tested, the (1)-N-(4-butoxybenzyl)-1,10-phenanthrolinium bromide exhibited the best in vitro anticancer activity with an IC50 27.60 ± 2.76 µM on HeLa, 6.42 ± 5.53 µM on NS-1 and 9.44 ± 2.17 µM on MCF-7 cell lines. Its SI were 377.65 ± 39.97 on HeLa, 6158.72 ± 5306.34 on NS-1 and 1140.11 ± 261.85 on MCF-7 cell lines. This study demonstrated that (1)-N-(4-butoxybenzyl)-1,10-phenanthrolinium bromide possessed a potential in vitro anticancer activity on cancer cell lines with high selectivity</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Gadjah Mada</dc:publisher>
	<dc:contributor xml:lang="en-US">Minister of Research &amp; Technology, Indonesian Government.</dc:contributor>
	<dc:date>2018-12-24</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Original Research Articles</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.ugm.ac.id/ijbiotech/article/view/33997</dc:identifier>
	<dc:identifier>10.22146/ijbiotech.33997</dc:identifier>
	<dc:source xml:lang="en-US">Indonesian Journal of Biotechnology; Vol 23, No 2 (2018); 68-73</dc:source>
	<dc:source>2089-2241</dc:source>
	<dc:source>0853-8654</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.ugm.ac.id/ijbiotech/article/view/33997/23736</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2018 The Author(s)</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-sa/4.0</dc:rights>
</oai_dc:dc>